<DOC>
	<DOCNO>NCT02736838</DOCNO>
	<brief_summary>Objectives : 1 . To analyze change peripheral tissue oxygenation tissue subject different pressure regimes healthy human . 2 . To analyze change microvascular flow peripheral tissue subject different pressure regimes healthy human . 3 . To determine threshold tissue perfusion flow transcutaneous oxygen depend exposure level angle pressure healthy volunteer . 4 . To evaluate distribution tissue perfusion flow transcutaneous oxygenation real clinical situation residential care acute hospital care patient risk impair skin integrity . Methodology : Experimental non-controlled , non-randomized study two phase : preclinical clinical . The first phase , conduct healthy volunteer second , patient risk impaired skin integrity . Vascular flow , tissue oxygenation local temperature area risk pressure ulcer Doppler laser evaluate subject lie capacitive surface measure pressure 10,249 point measurement , subject different body system generate different level pressure monitor change tissue perfusion oxygenation 4 hour , know implication reposition intervention patient risk .</brief_summary>
	<brief_title>Peripheral Perfusion Oxygenation Areas Risk Skin Integrity Impairment Exposed Pressure Patterns .</brief_title>
	<detailed_description>Sample : preclinical phase conduct 20 healthy volunteer enrol Faculty Health Sciences University Malaga . Clinical phase take place 12 subject admit acute hospitalization 'Costa del Sol ' Health Agency 12 subject admit nursing home District Primary Knowing information identify different threshold start peripheral microcirculation disorder associate various system body position consequent pressure level . This particular seem reasonable need baseline parameter allow explore specific situation tissue injury isolate direct indirect causal factor . It also necessary conduct study subject different environment ( home , hospital ) determine real clinical practice parameter behave affect common procedure perform clinical practice , reposition use pressure surface . This sample 24 subject calculate take account change capillary flow 30 % baseline first hour exposure pressure , accord data Kallman et al . ( 15 ) 80 % output statistical confidence level 95 % . In total , subject provide total 28 hour measurement . Phase 1 : Inclusion criterion : Healthy volunteer , 20 65 year old , cardiovascular , neurological , digestive , endocrine , renal , gynecological , respiratory , hematologic , infectious , dermatological , autoimmune diagnose musculoskeletal disease functional limitation , tissue integrity BMI 18.5 25.9 kg/cm2 without scar sacred , back-lumbar , trochanteric , heel , elbow shoulder blade area . Exclusion criterion : The usual consumption reason alpha-beta-blocking agent , alpha-beta agonist , directly indirectly vasodilator-vasoconstrictor action drug kind , anticoagulant , topical systemic steroid , presence pacemaker implantable defibrillator , smoking , high consumption alcohol ( &gt; 20g/week ) , presence tattoo area measurement , low limb amputation Phase 2 : Inclusion criterion : Patients admit acute hospitalization , risk skin integrity deterioration assess Braden scale ( punctuation lower 16 ) without pressure ulcer , agree participate study . Exclusion criterion : presence infusion vasoactive drug time study ( dopamine , epinephrine , norepinephrine , dobutamine , nitroprusside , nitroglycerin , calcium channel blocker , ACE inhibitor ) . Regular oral treatment alpha beta-blockers and/or agonist calcium channel blocker , nitrate , ACE inhibitor , angiotensin , renin inhibitor , diuretic , SSRIs , NSAIDs , accept . Also patient pacemaker and/or implant defibrillator , fever , anemia Hb &lt; 10g/dl , hypotension systolic blood pressure &lt; 80 mmHg , presence transfusion past 4 week , consumption derivative erythropoietin , iron supplement , oral parenteral anticoagulant exclude . Interventions : Different position apply subject order measure preipheral tissue oxygenation , pressure , change microvascular flow . The subject place standard position experiment : supine decubitus ( SD ) right lateral decubitus ( RLD ) , leave lateral decubitus ( LLD ) . SD measurement make 0 , 30 45 degree inclination bed . RLD LLD position evaluate body inclination 30 90 degree , aid pillow , do routine clinical practice . The subject lie memory foam mattress articulate bed , commonly use home , residential hospital care . Between subject mattress inserted pressure measure surface . Measurements position make interval 0-4 hour position ( SD-RLD-LLD ) inclination bed ( 0º , 30° , 45 ° ) body ( 30º , 90º ) , respectively . In case patient , institutional protocol set reposition frequency le 4 hour , measurement make maximum set protocol . Otherwise , maximum time position 4 hour . Measuring instrument : Pressure measurement make XSENSOR PX100 : 64.160.02 ( 31.2 x 203.2 cm ) pressure sensor , 12.7 mm space resolution , 10,240 measuring point . The pressure sensor compose two perpendicularly orient network parallel conductive strip , separate fine compressible elastomer . The intersection two strip form capacitive node , determine surface intersection two strip , distance separation , elastomer . When pressure apply node , elastomer compress , band approach capacity increase . This change capacitance correlate pressure calibration process . The pressure range able detect vary 0.2 3.87 psi . Tissue perfusion , oxygenation temperature assess area make system Periflux 5000 , compose 2 unit Laser Doppler Flowmetry ( LDF ) : PeriFlux 5001 , include laser source ; PeriFlux 5002 , provide temperature tissue oxygenation measurement . The information instrument collect integrated software allow simultaneous measurement signal . Tissue oxygenation measure transcutaneous oximetry ( TcpO2 ) , noninvasive procedure reflect amount oxygen diffuse capillary epidermis . This process depend state respiratory oxygenation , oxygen carry capacity blood overall circulatory condition . Any deterioration three member , immediately affect skin tissue perfusion , allow evaluate factor affect PU risk . It measure electrode heat underlie tissue create local hyperemia intensifies blood perfusion , consecuently , oxygen pressure increase . The heat dissolve lipid structure keratinize layer epidermis , allow skin permeability gas diffusion .</detailed_description>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>Phase 1 : Inclusion criterion : Healthy volunteer , 20 65 year old , female male participant study With cardiovascular , neurological , digestive , endocrine , renal , gynecological , respiratory , hematologic , infectious , dermatological , autoimmune diagnose musculoskeletal disease functional limitation , With tissue integrity BMI 18.5 25.9 kg/cm2 without scar sacred , backlumbar , trochanteric , heel , elbow shoulder blade area . Exclusion criterion : The usual consumption reason alphabetablocking agent , alphabeta agonist , Or directly indirectly vasodilatorvasoconstrictor action drug kind , •Anticoagulants , Topical systemic steroid , Presence pacemaker implantable defibrillator , Smoking , High consumption alcohol ( &gt; 20g/week ) , Presence tattoo area measurement , Lower limb amputation Phase 2 : Inclusion criterion : Patients ( female male ) , 18 85 year old , admit acute hospitalization , risk skin integrity deterioration assess Braden scale ( punctuation lower 16 ) Without pressure ulcer , Who agree participate study . Exclusion criterion : Presence infusion vasoactive drug time study ( dopamine , epinephrine , norepinephrine , dobutamine , nitroprusside , nitroglycerin , calcium channel blocker , ACE inhibitor ) . Regular oral treatment alpha betablockers And/or agonist calcium channel blocker , Nitrates , ACE inhibitor , Angiotensin , Renin inhibitor , Diuretics , SSRIs , NSAIDs , accept . Also patient pacemaker and/or implant defibrillator , Fever , Anemia Hb &lt; 10g/dl , Hypotension systolic blood pressure &lt; 80 mmHg , Presence transfusion past 4 week , Consumption derivatives erythropoietin , iron supplement , Oral parenteral anticoagulant exclude .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pressure</keyword>
	<keyword>Pressure Ulcer</keyword>
	<keyword>Skin perfusion</keyword>
	<keyword>Skin oxygenation</keyword>
</DOC>